Cargando…

PCAN: phenotype consensus analysis to support disease-gene association

BACKGROUND: Bridging genotype and phenotype is a fundamental biomedical challenge that underlies more effective target discovery and patient-tailored therapy. Approaches that can flexibly and intuitively, integrate known gene-phenotype associations in the context of molecular signaling networks are...

Descripción completa

Detalles Bibliográficos
Autores principales: Godard, Patrice, Page, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142268/
https://www.ncbi.nlm.nih.gov/pubmed/27923364
http://dx.doi.org/10.1186/s12859-016-1401-2
_version_ 1782472740729520128
author Godard, Patrice
Page, Matthew
author_facet Godard, Patrice
Page, Matthew
author_sort Godard, Patrice
collection PubMed
description BACKGROUND: Bridging genotype and phenotype is a fundamental biomedical challenge that underlies more effective target discovery and patient-tailored therapy. Approaches that can flexibly and intuitively, integrate known gene-phenotype associations in the context of molecular signaling networks are vital to effectively prioritize and biologically interpret genes underlying disease traits of interest. RESULTS: We describe Phenotype Consensus Analysis (PCAN); a method to assess the consensus semantic similarity of phenotypes in a candidate gene’s signaling neighborhood. We demonstrate that significant phenotype consensus (p < 0.05) is observable for ~67% of 4,549 OMIM disease-gene associations, using a combination of high quality String interactions + Metabase pathways and use Joubert Syndrome to demonstrate the ease with which a significant result can be interrogated to highlight discriminatory traits linked to mechanistically related genes. CONCLUSIONS: We advocate phenotype consensus as an intuitive and versatile method to aid disease-gene association, which naturally lends itself to the mechanistic deconvolution of diverse phenotypes. We provide PCAN to the community as an R package (http://bioconductor.org/packages/PCAN/) to allow flexible configuration, extension and standalone use or integration to supplement existing gene prioritization workflows. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12859-016-1401-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5142268
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51422682016-12-15 PCAN: phenotype consensus analysis to support disease-gene association Godard, Patrice Page, Matthew BMC Bioinformatics Software BACKGROUND: Bridging genotype and phenotype is a fundamental biomedical challenge that underlies more effective target discovery and patient-tailored therapy. Approaches that can flexibly and intuitively, integrate known gene-phenotype associations in the context of molecular signaling networks are vital to effectively prioritize and biologically interpret genes underlying disease traits of interest. RESULTS: We describe Phenotype Consensus Analysis (PCAN); a method to assess the consensus semantic similarity of phenotypes in a candidate gene’s signaling neighborhood. We demonstrate that significant phenotype consensus (p < 0.05) is observable for ~67% of 4,549 OMIM disease-gene associations, using a combination of high quality String interactions + Metabase pathways and use Joubert Syndrome to demonstrate the ease with which a significant result can be interrogated to highlight discriminatory traits linked to mechanistically related genes. CONCLUSIONS: We advocate phenotype consensus as an intuitive and versatile method to aid disease-gene association, which naturally lends itself to the mechanistic deconvolution of diverse phenotypes. We provide PCAN to the community as an R package (http://bioconductor.org/packages/PCAN/) to allow flexible configuration, extension and standalone use or integration to supplement existing gene prioritization workflows. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12859-016-1401-2) contains supplementary material, which is available to authorized users. BioMed Central 2016-12-07 /pmc/articles/PMC5142268/ /pubmed/27923364 http://dx.doi.org/10.1186/s12859-016-1401-2 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Software
Godard, Patrice
Page, Matthew
PCAN: phenotype consensus analysis to support disease-gene association
title PCAN: phenotype consensus analysis to support disease-gene association
title_full PCAN: phenotype consensus analysis to support disease-gene association
title_fullStr PCAN: phenotype consensus analysis to support disease-gene association
title_full_unstemmed PCAN: phenotype consensus analysis to support disease-gene association
title_short PCAN: phenotype consensus analysis to support disease-gene association
title_sort pcan: phenotype consensus analysis to support disease-gene association
topic Software
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142268/
https://www.ncbi.nlm.nih.gov/pubmed/27923364
http://dx.doi.org/10.1186/s12859-016-1401-2
work_keys_str_mv AT godardpatrice pcanphenotypeconsensusanalysistosupportdiseasegeneassociation
AT pagematthew pcanphenotypeconsensusanalysistosupportdiseasegeneassociation